6:30pm: The suspension will save the Mets $1.2MM per Mike Puma of the New York Post (tweet).
Rubin tweets that Mejia will not be eligible for the postseason roster if the Mets qualify for the playoffs.
6:20pm: Mejia is the fourth pitcher in the last 15 days to test positive for Stanozolol, reports Adam Rubin of ESPN New York. In addition to Santana, Mariners pitcher David Rollins and Braves pitcher Arodys Vizcaino are serving suspensions after failing a drug test. Three of the four players are Dominican, which might provide a clue as to how or where the drug is being disseminated. Like Mejia, Santana also claimed that he had no knowledge of how the drug entered his system.
As a reminder, days on the disabled list count towards the suspension, so Mejia will simply be out longer than expected, tweets Matt Ehalt of The Record. Per Ehalt, Mejia will not appeal the suspension. He is eligible to return on July 7 against the Giants (Twitter).
Andy Martino of the New York Daily News adds (on Twitter) that the Mets won’t pursue an external option like Rafael Soriano. They’re satisfied with their current depth.
4:37pm: Mets closer Jenrry Mejia has received an 80-game suspension without pay after testing positive for Stanozolol, MLB has announced. Stanozolol is the same performance-enhancing drug Ervin Santana was suspended earlier this month for using.
“We were disappointed when informed of Jenrry’s suspension for violating Major League Baseball’s Joint Drug Prevention and Treatment Program,” say the Mets in a statement. “We fully support MLB’s policy toward eliminating performance enhancing substances from the sport. As per the Joint Drug Program, we will have no further comment on this suspension.”
“I know the rules are the rules and I will accept my punishment,” says Mejia, seemingly suggesting he will not appeal the suspension. “[B]ut I can honestly say I have no idea how a banned substance ended up in my system. … I’m sorry to the Mets organization, my teammates and the fans, as well as my family.”
Mejia had not pitched in 2015 due to elbow inflammation. An MRI showed no structural damage, so he likely would have returned at some point fairly soon if not for the suspension. Mejia racked up 28 saves in 2014 while carrying a relatively heavy workload for a closer, pitching 93 2/3 innings with a 3.65 ERA, 9.4 K/9 and 3.9 BB/9. Jeurys Familia will likely get most save opportunities in his absence. Mejia was set to make $2.595MM in his first arbitration year in 2015, but now the Mets will only have to pay him about half that amount.